These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 10954064)
1. Low dosage of levomepromazine did not increase plasma concentrations of fluvoxamine. Yoshimura R; Ueda N; Nakamura J Int Clin Psychopharmacol; 2000 Jul; 15(4):233-5. PubMed ID: 10954064 [TBL] [Abstract][Full Text] [Related]
2. An autopsy case of intoxication caused by drug interaction with multiple psychotropic drugs, fluvoxamine, levomepromazine, and trihexyphenidyl. Takei S; Kinoshita H; Jamal M; Yamashita T; Tanaka E; Kawahara S; Abe H; Tsutsui K; Murase T Leg Med (Tokyo); 2024 Sep; 70():102482. PubMed ID: 38959586 [TBL] [Abstract][Full Text] [Related]
3. A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder. Hori H; Yoshimura R; Ueda N; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J World J Biol Psychiatry; 2009; 10(4 Pt 2):620-2. PubMed ID: 18609433 [TBL] [Abstract][Full Text] [Related]
4. Seizures induced by combined levomepromazine-fluvoxamine treatment. Grinshpoon A; Berg Y; Mozes T; Mester R; Weizman A Int Clin Psychopharmacol; 1993; 8(1):61-2. PubMed ID: 8473723 [TBL] [Abstract][Full Text] [Related]
5. Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data. Wylie ME; Miller MD; Shear MK; Little JT; Mulsant BH; Pollock BG; Reynolds CF J Geriatr Psychiatry Neurol; 2000; 13(1):43-8. PubMed ID: 10753007 [TBL] [Abstract][Full Text] [Related]
6. Effect of fluvoxamine on panic disorder. Hoehn-Saric R; McLeod DR; Hipsley PA J Clin Psychopharmacol; 1993 Oct; 13(5):321-6. PubMed ID: 8227490 [TBL] [Abstract][Full Text] [Related]
7. Concentration-response relationship for fluvoxamine using remission as an endpoint: a receiver operating characteristics curve analysis in major depression. Suzuki Y; Fukui N; Sawamura K; Sugai T; Watanabe J; Ono S; Inoue Y; Ozdemir V; Someya T J Clin Psychopharmacol; 2008 Jun; 28(3):325-8. PubMed ID: 18480690 [TBL] [Abstract][Full Text] [Related]
8. Effect of Genetic Polymorphism of the CYP2D6 Gene on the Efficacy and Safety of Fluvoxamine in Major Depressive Disorder. Zastrozhin M; Skryabin V; Smirnov V; Zastrozhina A; Grishina E; Ryzhikova K; Bure I; Golovinskii P; Koporov S; Bryun E; Sychev D Am J Ther; 2021 Jun; 29(1):e26-e33. PubMed ID: 34117140 [TBL] [Abstract][Full Text] [Related]
9. Dose-dependent effect of the CYP2D6 genotype on the steady-state fluvoxamine concentration. Watanabe J; Suzuki Y; Fukui N; Sugai T; Ono S; Inoue Y; Someya T Ther Drug Monit; 2008 Dec; 30(6):705-8. PubMed ID: 18978520 [TBL] [Abstract][Full Text] [Related]
10. A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia. Bakish D; Hooper CL; Filteau MJ; Charbonneau Y; Fraser G; West DL; Thibaudeau C; Raine D Psychopharmacol Bull; 1996; 32(1):135-41. PubMed ID: 8927663 [TBL] [Abstract][Full Text] [Related]
11. Little effects of low dosage of levomepromazine on plasma risperidone levels. Yoshimura R; Shinkai K; Kakihara S; Goto M; Yamada Y; Kaji K; Ueda N; Nakamura J Pharmacopsychiatry; 2005 Mar; 38(2):98-100. PubMed ID: 15744635 [TBL] [Abstract][Full Text] [Related]
13. Fluvoxamine strongly inhibits melatonin metabolism in a patient with low-amplitude melatonin profile. Grözinger M; Härtter S; Wang X; Röschke J; Hiemke C; Rose DM Arch Gen Psychiatry; 2000 Aug; 57(8):812-3. PubMed ID: 10920471 [No Abstract] [Full Text] [Related]
14. Augmentative effects of fluvoxamine on duloxetine plasma levels in depressed patients. Paulzen M; Finkelmeyer A; Grözinger M Pharmacopsychiatry; 2011 Nov; 44(7):317-23. PubMed ID: 21979923 [TBL] [Abstract][Full Text] [Related]
15. Interaction between fluvoxamine and cotinine or caffeine. Yoshimura R; Ueda N; Nakamura J; Eto S; Matsushita M Neuropsychobiology; 2002; 45(1):32-5. PubMed ID: 11803239 [TBL] [Abstract][Full Text] [Related]
16. [The effect of mexidol in the combination with antidepressants on sleep disturbance in young patients with panic disorder]. Kursakov ES; Remizevich RS Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2):33-8. PubMed ID: 23528580 [TBL] [Abstract][Full Text] [Related]
17. Increased plasma concentrations of bromperidol and its reduced metabolite with levomepromazine, but not with thioridazine. Suzuki A; Otani K; Ishida M; Yasui N; Kondo T; Mihara K; Kaneko S; Inoue Y; Shibata M; Ikeda K Ther Drug Monit; 1997 Jun; 19(3):261-4. PubMed ID: 9200764 [TBL] [Abstract][Full Text] [Related]
18. Fluvoxamine and fluoxetine: interaction studies with amitriptyline, clomipramine and neuroleptics in phenotyped patients. Vandel S; Bertschy G; Baumann P; Bouquet S; Bonin B; Francois T; Sechter D; Bizouard P Pharmacol Res; 1995 Jun; 31(6):347-53. PubMed ID: 8685072 [TBL] [Abstract][Full Text] [Related]
19. An open trial of fluvoxamine therapy for panic disorder complicated by depression. Spiegel DA; Saeed SA; Bruce TJ J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679 [TBL] [Abstract][Full Text] [Related]